成人重症监护病房肾脏替代治疗:ISCCM专家小组实践推荐
该推荐由印度重症监护医学会(ISCCM)专家小组制定,经重症医师和肾内科医师讨论形成,旨在优化ICU内急性肾损伤(AKI)患者的肾脏替代治疗(RRT)启动与管理。文件指出连续性治疗在需要中高剂量血管活性药物的血流动力学不稳定患者中优先于间歇性治疗,并强调受过培训的重症医师应参与从识别RRT指征、开具处方、根据代谢需求调整到肾功能恢复后停机的全程管理,同时肾内科团队的参与至关重要。推荐强烈建议完善记录以保证质量并助益未来研究。该推荐代表专家意见和实践模式,并非仅基于证据或系统文献综述,但制定时回顾了现有指南和文献。
要点
- 血流动力学不稳定、需要中高剂量血管活性药物的AKI患者,优先选择连续性RRT而非间歇性治疗。
- 受过培训的重症医师应参与AKI患者RRT管理的所有环节:识别RRT指征、开具处方、根据代谢需求调整方案及肾功能恢复后停机。
- 肾内科团队参与AKI管理至关重要,推荐多学科协作管理ICU多器官功能障碍的危重患者。
- 强烈推荐完善记录,既保证质量,也有助于未来研究。
- 该推荐代表专家意见和实践模式,并非仅基于证据或系统文献综述,但制定时回顾了现有指南和文献。
适用人群与场景
- 成人重症监护病房(ICU)中发生急性肾损伤(AKI)的患者,病因可能为多因素。
- 经医学管理(包括预防AKI和优化血流动力学)无反应、可能需要肾脏替代治疗(RRT)的AKI患者。
处置流程与药物剂量
- AKI管理策略重点在于预防AKI并优化血流动力学;对医学管理无反应者可能需要RRT。
- RRT选项包括间歇性治疗和连续性治疗;血流动力学不稳定、需要中高剂量血管活性药物的患者优先选择连续性治疗。
- 受过培训的重症医师必须参与AKI患者RRT管理的所有环节:识别需要RRT的患者、开具处方、根据患者代谢需求修改处方、肾功能恢复后停止治疗。
- 推荐多学科协作管理ICU中多器官功能障碍的危重患者;肾内科团队参与AKI管理至关重要。
- 强烈推荐完善记录,以保证质量并助益未来研究。
研究设计与关键结果
- 该推荐由ISCCM专家小组制定,经代表印度ICU多样化重症实践的重症医师和肾内科医师适当讨论后形成。
- 文件目的是借助受过培训的重症医师,优化RRT实践(启动和管理),以有效、及时地管理AKI患者。
- 推荐代表专家意见和实践模式,并非仅基于证据或系统文献综述;但制定时回顾了现有指南和文献以支持推荐。
证据类型、等级与局限
- 证据类型:专家小组实践推荐(ISCCM专家小组)。
- 推荐代表专家意见和实践模式,并非仅基于证据或系统文献综述;制定时回顾了现有指南和文献。
- 局限:原文未报告局限性
对床旁实践的改变
- 对血流动力学不稳定、需要中高剂量血管活性药物的AKI患者,优先选择连续性RRT而非间歇性治疗。
- 受过培训的重症医师应参与RRT全程管理,包括识别指征、开具和调整处方、肾功能恢复后停机。
- 肾内科团队应参与AKI管理,推荐多学科协作。
- 强烈推荐完善记录以保证质量并助益未来研究。
- 该推荐代表专家意见和实践模式,并非仅基于证据或系统文献综述。
指南或共识出处
- ISCCM专家小组实践推荐:成人重症监护病房肾脏替代治疗(Renal Replacement Therapy in Adult Intensive Care Unit: An ISCCM Expert Panel Practice Recommendation),Indian J Crit Care Med 2022;26(S2):S3-S6。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Acute kidney injury (AKI) contributes significantly to morbidity and mortality in ICU patients. The cause of AKI may be multifactorial and the management strategies focus primarily on the prevention of AKI along with optimization of hemodynamics. However, those who do not respond to medical management may require renal replacement therapy (RRT). The various options include intermittent and continuous therapies. Continuous therapy is preferred in hemodynamically unstable patients requiring moderate to high dose vasoactive drugs. A multidisciplinary approach is advocated in the management of critically ill patients with multi-organ dysfunction in ICU. However, an intensivist is a primary physician involved in life-saving interventions and key decisions. This RRT practice recommendation has been made after appropriate discussion with intensivists and nephrologists representing diversified critical care practices in Indian ICUs. The basic aim of this document is to optimize renal replacement practices (initiation and management) with the help of trained intensivists in the management of AKI patients effectively and promptly. The recommendations represent opinions and practice patterns and are not based solely on evidence or a systematic literature review. However, various existing guidelines and literature have been reviewed to support the recommendations. A trained intensivist must be involved in the management of AKI patients in ICU at all levels of care, including identifying a patient requiring RRT, writing a prescription and its modification as per the patient's metabolic need, and discontinuation of therapy on renal recovery. Nevertheless, the involvement of the nephrology team in AKI management is paramount. Appropriate documentation is strongly recommended not only to ensure quality assurance but also to help future research as well.
HOW TO CITE THIS ARTICLE: Mishra RC, Sinha S, Govil D, Chatterjee R, Gupta V, Singhal V, et al. Renal Replacement Therapy in Adult Intensive Care Unit: An ISCCM Expert Panel Practice Recommendation. Indian J Crit Care Med 2022;26(S2):S3-S6.
参考来源
- Mishra RC, Sinha S, Govil D, et al. Renal Replacement Therapy in Adult Intensive Care Unit: An ISCCM Expert Panel Practice Recommendation. Indian J Crit Care Med. 2022. PMID: 36896362. doi:10.5005/jp-journals-10071-24278
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。